StockNews.com began coverage on shares of L.S. Starrett (NYSE:SCX – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a buy rating on the stock.
L.S. Starrett Price Performance
Shares of NYSE:SCX opened at $16.11 on Tuesday. The company has a current ratio of 3.11, a quick ratio of 1.42 and a debt-to-equity ratio of 0.02. The stock has a market cap of $120.99 million, a PE ratio of 6.27 and a beta of 0.46. The stock’s fifty day simple moving average is $14.39 and its two-hundred day simple moving average is $12.45. L.S. Starrett has a 1-year low of $8.55 and a 1-year high of $16.17.
L.S. Starrett (NYSE:SCX – Get Free Report) last released its quarterly earnings results on Friday, February 16th. The company reported ($0.05) earnings per share for the quarter. L.S. Starrett had a net margin of 7.72% and a return on equity of 3.45%. The firm had revenue of $62.08 million for the quarter.
Hedge Funds Weigh In On L.S. Starrett
L.S. Starrett Company Profile
The L.S. Starrett Company, together with its subsidiaries, manufactures and sells industrial, professional, and consumer measuring and cutting tools, and related products in North America, Brazil, and China. The company's products include precision tools, electronic gauges, gage blocks, optical vision and laser measuring equipment, custom engineered granite solutions, tape measures, levels, chalk products, squares, band saw blades, hole saws, hacksaw blades, jig saw blades, and reciprocating saw blades, as well as M1 lubricant and precision ground flat stock products.
Further Reading
- Five stocks we like better than L.S. Starrett
- How to Use the MarketBeat Dividend Calculator
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- How to Choose Top Rated Stocks
- Hilton Demonstrates Asset Light is Right for Investors
- Investing in Commodities: What Are They? How to Invest in Them
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for L.S. Starrett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for L.S. Starrett and related companies with MarketBeat.com's FREE daily email newsletter.